Page 1694 - Clinical Small Animal Internal Medicine

1632 Index

rectoanal diseases 609–620 rescue chemotherapy 1234–1235 rhabdomyosarcoma 1272
VetBooks.ir anal sac impaction 610–611 respiratory disease diagnosis 1000, 1000
anal sac adenocarcinoma 609–610
rhinosporidiosis 999–1000
respiratory auscultation 124–125
atresia ani and rectoanal
epidemiology and
canine distemper virus
strictures 611–612, 611 851–852 signalment 1000
constipation, obstipation, and canine infectious respiratory disease etiology/pathophysiology
megacolon 612–613, 613 complex 1035–1038 999–1000
foreign bodies 615–616 feline viral upper respiratory tract history and clinical signs 1000
perianal fistulae 613–614, disease 887–889 public health implications 1000
614, 615 nonhemotropic Mycoplasma, treatment and prognosis 1000
polyps 616–617, 616 Ureaplasma, and L‐form RIA see radioimmunoassay
pseudocoprostasis 614–615 bacteria 933 rickets and osteomalacia
rectal prolapse 617–618, 617 respiratory monitoring in critical 1524–1527
rectal tumors 618–620, 619 care 373–380 diagnosis 1525–1526, 1526
tears and trauma 618 assessment of the adequacy of etiology/pathophysiology 1524
recumbent patient care 400 alveolar ventilation history and clinical signs 1525
recurrent urinary tract infections 376–377, 376 inherited rickets 1526–1527
1191–1192 assessment of the adequacy of signalment 1525
red blood cells (RBC) 350–351 oxygenation 377–378 treatment and prognosis 1526
reference ranges 9–10 clinical signs of dyspnea Rickettsia spp. 250, 937–940
referral 375–376 RIFLE see Risk Injury Failure End Stage
behavioral problems 1574–1577, clinical signs of respiratory Kidney Disease
1575, 1576 distress 373–375, 374 right bundle branch block
critical care setting 348–349 determination of response to (RBBB) 172–173, 173
motility disorders 568–569 specific or empiric right heart catheterization 227
reflexes therapies 376 right‐sided congestive heart
head trauma 752–753 evaluation of gas exchange failure 132
myelopathy 818 efficiency 378–379 right‐to‐left shunting 384, 389
neurologic assessment 732–733, identifying respiratory distress and right ventricular hypertrophy 132,
734–735 dyspnea 373–376 134, 138, 172, 173
refractory head trauma 757–758 purpose 373 rinses 1397–1398
refractory heart failure 250 use of pulmonary mechanics to Risk Injury Failure End Stage Kidney
regulatory T cells (Treg) 1208 categorize disease 380 Disease (RIFLE) 1091
rehabilitation 455 resting energy requirement risk ratios 20
reinduction chemotherapy 1234 (RER) 453, 599 RIT see rush immunotherapy
renal disease 1242 restrictive cardiomyopathy (RCM) Rocky Mountain spotted fever
renal failure 107 cardiogenic shock 415 937–940
renal function 351 cardiovascular disease 124 ROS see reactive oxygen species
renal hemangiosarcoma 1341 feline myocardial disease 267, ROSC see return of spontaneous
renal lymphoma 1237–1239 269–270 circulation
renin‐angiotensin‐aldosterone system heart failure 190 ROTEM see thromboelastometry
(RAAS) retained cartilaginous core RSAT see rapid slide agglutination test
canine myocardial disease 260–261 1545–1546 RT see radiation therapy
feline myocardial disease 273 reticuloendothelial system (RES) RTK see receptor tyrosine kinase
glomerular disease 1103–1105 1049–1050 RT‐PCR see polymerase chain reaction
heart failure 179–180, 186, retinal toxicity 1046 Rule of 20, 349–352
188–189, 196–197 retinoid therapy 1356 rush immunotherapy (RIT)
shock 404–405 retrograde contrast 302–303
sodium and water urethrocystography 1158
homeostasis 1070 retrograde transit 567 s
systemic hypertension 219, 222 retroperitoneal hemangiosarcoma SA see sebaceous adenitis
valvular heart disease 245–246 1341 salivary glands see oral cavity and
reperfusion 446 return of spontaneous circulation salivary glands
RER see resting energy requirement (ROSC) 365, 368–371 salivary staining 1404, 1405
RES see reticuloendothelial system reverberation 664 Salmonella spp. 1060